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[571 ABSTRACT 
Normal mammalian tissue and the culturing process has 
been developed for the three groups of organ, structural and 
blood tissue. The cells are grown in vitro under micro- 
gravity culture conditions and form three dimensional cells 
aggregates with normal cell function. The microgravity 
culture conditions may be microgravity or simulated micro- 
gravity created in a horizontal rotating wall culture vessel. 
The medium used for culturing the cells, especially a mix- 
ture of epithelial and mesenchymal cells contains a mixture 
of Mem-alpha and Leibovits L15 supplemented with 
glucose, galactose and fructose. 
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PRODUCTION OF NORMAL MAMMALIAN 
ORGAN CULTURE USING A MEDIUM 
15, GLUCOSE GALACTOSE FRUCTOSE 
CONTAINING MEM-ALPHA, LEIBOVITZ L- 
This is a division of application Ser. No. 081066,292, 
filed May 25, 1993 now U.S. Pat. No. 5,496,722. 
ORIGIN OF THE INVENTION 
The invention described herein was made in the perfor- 
mance of work under a NASA contract and is subject to the 
provisions of Section 305 of the National Aeronautics and 
Space Act of 1958, Public Law 85-568 (72 Stat. 435; 42 
U.S.C. 2457). 
RELATED PATENTS AND APPLICATIONS 
The present case is a continuation in part of U.S. patent 
application Ser. No. 071939,791 filed Sep. 3, 1992 entitled 
“Three-Dimensional Coculture Process” which is a continu- 
ing application of Ser. No. 071317,931 filed Mar. 2, 1989 
entitled “Three-Dimensional Coculture Process” now U.S. 
Pat. No. 5,153,132 issued Oct. 6, 1992 which is a 
continuation-in-part of Ser. No. 317,776 filed Mar. 2, 1989 
entitled “Three Dimensional Cell and Tissue Assembly 
Process” now U.S. Pat. No. 5,155,034 issued Oct. 13, 1992 
which is a continuation-in-part of Ser. No. 213,588, filed 
Jun. 30, 1988, now U.S. Pat. No. 5,026,650, issued Jun. 25, 
1991 entitled “Horizontally Rotated Cell Culture System 
with a Coaxial Tubular Oxygenator” and Ser. No. 213,559 
filed Jun. 30, 1988, now U.S. Pat. No. 4,988,623 issued Jan. 
29, 1991 entitled “Rotating BioReactor Cell Culture Appa- 
ratus” and Ser. No. 625,345 filed Dec. l l ,  1990 now U.S. 
Pat. No. 5,153,131, issued Oct. 6, 1992 entitled “High 
Aspect Reactor Vessel and Method of Use”, all of which are 
specifically incorporated as if fully set forth herein. 
FIELD OF THE INVENTION 
The invention relates to production of functional three 
dimensional mammalian tissue from a culture of normal 
cells in fluid media. 
BACKGROUND OF THE INVENTION 
The culturing of mammalian cells presents many chal- 
lenges as compared to bacteria, yeast and molds. Bacterial- 
type cells have tougher outer cell walls and can be manipu- 
lated without injuring the cells during culture, whereas 
mammalian cells are delicate and cannot withstand stress. 
Bacterial-type cells are not organized into functional tissue 
groups with cell differentiation or organization as seen in 
higher life forms such as mammals. 
Mammalian tissue can be grouped into three general 
categories of (1) organ tissue (2) structural tissue and (3) 
blood producing tissue. Mammalian tissue is composed of 
aggregates of cells that share a functional interrelationship in 
order to have tissue growth. Mammalian tissue is composed 
of different types of cells characterized by different mor- 
phology and immunochemical properties. Cellular differen- 
tiation in mammals involves complex interactions in which 
cell membrane junctions, extracellular matrices such as 
basement membrane and ground substances. Soluble signals 
produced and shared among the cells play an important role. 
Study of normal mammalian tissue, however, has been 
limited because of lack of adequate in vitro culture systems 
that product tissue of sufficient size and functionality. In 
contrast, tumor cells are by their nature easier to grow in 
2 
vitro, possess abnormal growth characteristics and do not 
behave like normal cells in their interaction with neighbor- 
ing cells. Sutherland, “Cell and Environment Interactions in 
Tumor Microregions: The Multicell Spheroid Model”, 
5 Science, Vol. 240, pp. 177-240, 8 Apr. 1988. Different 
culture methods for normal and abnormal mammalian cells 
have been used. Elaborate culture systems for normal mam- 
malian cells have been developed in an attempt to grow 
normal tissue. 
A variety of different cells and tissues, such as bone 
marrow, skin, liver, pancreas, mucosal epithelium, adeno- 
carcinoma and melanoma, have been grown in culture 
systems to provide three dimensional growth in the presence 
of a preestablished stromal support matrix. U.S. Pat. No. 
1~ 4,963,489, Three-Dimensional Cell and Tissue Culture 
System, Naughton, et al., Oct. 16, 1990; U.S. Pat. No. 
5,032,508, Three-Dimensional Cell and Tissue Culture 
System, Naughton, et al., Jul. 16, 1991. A biocompatible, 
non-living material formed into a three dimensional struc- 
2o ture is inoculated with stromal cells. In some cases, the three 
dimensional structure is a mesh pre-coated with collagen. 
Stromal cells and the associated connective tissue proteins 
naturally secreted by the stromal cells attach to and envelop 
the three dimensional structure. The interstitial spaces of the 
25 structure become bridged by the stromal cells, which are 
grown to at least subconfluence prior to inoculating the three 
dimensional stromal matrix with tissue-specific cells. 
Normal mammalian tissue has been grown for limited 
periods of time as two-dimensional monolayers on gelled 
30 substrate or other surface for anchoring the cells. Adult 
colonic epithelial cells have been found to be more difficult 
to culture than fetal colonic epithelial cells. Buset et al. 
“Defining Conditions to Promote the Attachment of Adult 
Human Colonic Epithelial Cells”, In vltro Cell. & Dev. Biol., 
35 Vol. 23. No. 6 pp. 403-412 (June 1987). To mimic a more 
normal environment using monolayer culture, cocultures 
were prepared using two cell types, often with a “feeder 
layer” of fibroblasts or other cells to supply the primary cells 
with nutrients and other factors difficult to incorporate into 
40 a substrate and to provide the cellular interaction believed to 
be necessary for the production of differentiated tissue. Reid 
et al., “Culturing Hepatocytes and Other Differentiated 
Cells”, Hepatology, Vol. 4, No. 3, pp. 548-559 (1984); 
Haake et al. “Retention of Differentiated Characteristics in 
45 Human Fetal Keratinocytes In Vitro”, In vltro Cell. & Dev. 
Biol., Vol. 25 No. 25 pp. 592-600 (July 1989). Also, 
monolayers “conditioned” with fibroblast cells have been 
used to impart into the substrate the soluble growth factors 
for epithelial cells. Kabalin et al. “Clonal Growth of Human 
50 Prostatic Epithelial Cells Is Stimulated by Fibroblasts”, The 
Prostate, Vol. 14, pp. 251-263 (1989). Monolayers do not 
produce a three dimensional tissue, but rather a two- 
dimensional spread of cells. Often the cells developed by 
monolayer culture and coculture become undifferentiated 
Three dimensional in vitro models of differentiated tissue 
have been produced, however, the cells often do not dem- 
onstrate normal cellular activity. Embryonic avian skeletal 
muscle cells have been grown in vitro on expandable 
60 membranes which are gradually and substantially, continu- 
ously stretched to simulate the mechanical stimulation of 
cells experienced in vivo. U.S. Pat. No. 4,940,853, Method 
for Growing Tissue Specimens in Vitro, Vadenburgh, Jul. 10, 
1990. The expandable support membrane supports develop- 
65 ment of three dimensional structures which more closely 
resemble tissue grown in vivo, however, normal indepen- 
dent cellular activity was not identified. Additionally, three 
5s and lack normal function. 
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dimensional human mammary epithelial cells have been 
grown in collagen. U.S. Pat. No. 5,026,637, Soule, et al., 
Jun. 25, 1991. However, the cells, under the culture 
conditions, did not undergo terminal differentiation and cell 
senescence, but rather were “immortal” in that they retained 
the capacity to divide forever. Thus, normal cellular activity 
and naturalization was not observed. 
The study of the organ systems exemplifies the complex 
interrelationship of neighboring cells in mammalian tissue 
necessary for normal three dimensional tissue growth. Mam- 
malian organ systems have been studied to determine the 
relationship of the cell types that make up the organ as well 
as their effects on each other. Studies on normal tissue 
differentiation have indicated an important interaction 
between epithelial cells and mesenchymal cells and the 
production and differentiation of the cells from fibroblasts. 
Kaye et al., “The Colonic Pericryptal Fibroblast Sheath: 
Replication, Migration, and Cytodifferentiation of a Mesen- 
chymal Cell System in Adult Tissue” Gastroenterology, Vol. 
60. No. 4, pp. 515-536 (1971). Furthermore, small intestine 
tissue is exemplary of organ tissue types with epithelial cells 
with functional brush borders and organized columnar cells 
associated with mesenchymal cells. Other organs have simi- 
lar organization. Small intestine tissue has physical support 
in vivo so that the tissue forms crypts which increase the 
surface area of the organ. In addition to the crypt formation 
in vivo, there are also immunocytochemical markers for 
particular cell types with normal functionality as well as cell 
types that are in developmental phases to produce functional 
organ tissue. 
Immunochemical properties further characterize normal 
cells types and tissue. Keratin, vimentin and Factor VI11 
antibodies detect epithelial, fibroblastic and endothelial cells 
respectively. Villin is a cytoskeletal protein only found in 
epithelial cells from the small intestine and colon. The 
angioblast marker is present in certain precursor endothelial 
cells, particularly dividing cells. Sucrase is an enzyme found 
in the epithelial cell brush border of the small intestine. 
Basement membrane and extracellular matrix components 
such as laminin, fibronectin, Collagen IV, and proteoglycan 
are associated with ordering of tissue and cellular polarity. 
Basement membrane and extracellular matrix development 
has been related to epithelial-mesenchymal development 
and differentiation. All these components are necessary for 
normal tissue growth. 
Culture of normal or neoplastic small intestine epithelium 
as large-scale three dimensional configurations has not been 
shown with routinely used in vitro culture technology. 
Chantret et al., “Epithelial Polarity, Villin Expression and 
Eterocytic Differentiation of Cultured Human Colon Carci- 
noma Cells: A survey of Twenty Cell Lines” Cancer Res., 
Vol. 48, pp. 1936-1942 ( Apr. 1, 1988). Factors that control 
proliferation and differentiation in the gastrointestinal tract 
remain largely unknown. Corps et al., “Stimulation of Intes- 
tinal Epithelial Cell Proliferation in Culture by Growth 
Factors in Human and Ruminant Mammary Secretions” J .  
Endocr., Vol. 113, pp. 285-290 (3 Nov. 1986); O’Loughlin 
et al., “Effect of Epidermal Growth Factor on Ontogeny of 
the Gastrointestinal Tract” Am. J .  Physiol., Vol. 249, pp. 
G674G678 (8 Jul. 1985); Blay et al., “Contradistinctive 
Growth Responses of Cultured Rat Intestinal Epithelial 
Cells to Epidermal Growth Factor Depending on Cell Popu- 
lation Density” J.  of Cell. Physiol., Vol. 129, pp. 343-346 
(15 Jul. 1986). 
Cartilage tissue is exemplary of normal structural tissue. 
Attempts have been made to encourage cartilage formation 
in vitro by culturing chondrocytes. Typical culture durations 
4 
achieved in the more successful instances range from 10 
days to 30 days, the 30-day point being a transition towards 
static culture or cellular degeneration and death. The success 
achieved to date has had limited 3-dimensionality. Typical 
s cell culture methodologies include isolating chondrocytes 
from various articular surfaces and plating the isolated 
chondrocytes as a monolayer in a T-flask. Various manipu- 
lations were then utilized to encourage chondrocyte expan- 
sion and differentiation, and the deposition of proteoglycan 
i o  into the interstitial matrices. These maneuvers include vari- 
ous growth factor augmentations, an effort to emulate in situ 
conditions. The extent to which the cells can be maintained 
in situ is on the order of tens of years as seen in the normal 
adult. Conversely, in standard cell culture the extent which 
is cells can be maintained in a growth phase or a normal static 
maintenance phase is on the order of 22 days. It has been 
demonstrated that multiple cell-surface receptors exist that 
are important in cellular growth and differentiation, and 
extracellular matrix formation. Cell surface receptors are 
20 labile to destructive cell surface sheer. 
Cartilage cells were reportedly cultured for 13 months 
using a solid substrate in conventional culture vessels. U.S. 
Pat. No. 4,757,017 Cheung et al., Jul. 12, 1988. The solid 
substrate was a porous calcium compound. Multilayer cell 
2s growth was observed and the cells maintained their pheno- 
type. 
Bone marrow has been grown using conventional mono- 
layer cell culture technique. Human bone marrow cell cul- 
ture technique. Human bone marrow cell production 
30 declines over time in monolayer culture. Naughton et. al. 
disclosed a bone marrow culture system in co-culture with 
stromal cells or mixtures of cell types on a three dimensional 
support. U.S. Pat. No. 4,963,489. The three dimensional 
support was coated by cells such as fetal fibroblasts over a 
Mammalian tissue has been grown in bioreactors provid- 
ing low shear from abnormal cell types such as tumor cells 
or cocultures with normal and tumor cells. Goodwin et al., 
4o “Morphological Differentiation of Colon Carcinoma Cell 
Lines HT-29 and HT-29K in Rotating-Wall Vessels,” In Vitro 
Cell. Dev Biol. Vol. 28A, pp. 47-60, January 1992. The 
bioreactor designs are disclosed in U.S. Pat. Nos. 4,988,623; 
5,026,650 and 5,153,131. Co-culture of tumor and normal 
4s cells in solid-state culture has been reported as shown in 
U.S. Pat. No. 4,352,887 to Reid et al. issued Oct. 5, 1982. 
However, since tumor or abnormal cells grow under condi- 
tions that normal cells cannot tolerate, the growth of non- 
normal cells does not predict success for normal mammalian 
There are many potential uses of artificially produced 
tissue for different mammalian systems. For example, small 
intestine tissue can be used as a model for the molecular and 
clinical treatment of diseases such as inflammatory bowel 
5s disease (Crohn’s, ulcerative colitus), malabsorptive syn- 
dromes (short-gut syndrome), numerous infectious diseases 
and tumors of the small bowel. The tissue can be a model for 
the therapeutic trials prior to in vivo experimentation. How- 
ever cultures longer than 7 weeks have been difficult to 
60 achieve, since crypt cells are unable to survive standard 
culture regimens, and two-dimensional organ cultures do not 
support the de novo assembly of stroma and its contribution 
to epithelial cell growth. Shamsuddin, “Colon Organ Culture 
as a Model for Carcinogenesis”, Colon Cancer Cells, Moyer 
Also, a mammalian structural tissue such as a cartilage 
model of high fidelity is important in clinical studies. There 
3s collagen layer on a mesh support. 
so culture under the same or similar culture conditions. 
65 and Poste, Eds. Academic Press, Inc. 1990. 
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are numerous maladies associated with cartilage, including thelia1 cells and functional mesenchymal cells. Also, the 
but not limited to knee-joint injuries, back injuries, articular- tissue developed cells inmunochemically characterized as 
surface injuries, inflammatory diseases such as arthritis and functional endothelial precursor cells in significantly greater 
temporal-mandibular joint disease. Beyond the diseases are numbers than were present in the initial inoculum. The organ 
the natural processes of maturation through puberty and the 5 tissue mass also developed cells immunochemically char- 
geriatric inability to repair and maintain articular surfaces. A acterized as functional angioblasts and cells that were immu- 
tissue model would be beneficial for the analyses and nochemically characterized as functional epithelial cell 
development of therapeutic protocols. Moreover, these mod- brush borders. Organized columnar cells were clearly vis- 
els become essential in tailoring pharmaceuticals, i.e.; non- ible. The developing organ tissue included cells immu- 
steroidal anti-inflammatories where the pharmaceutical may nochemically characterized as basement membrane compo- 
actually become detrimental to the chondrocyte by way of nents. As the tissue masses grew anchored to microcarriers 
degradation into secondary metabolites. they were joined with cord-like structures of fibroblasts 
The artificial production of functional blood tissue such as covered by 
normal bone marrow could be used in patients in need of A Preferred fluid media for m m m d i a n  organ tissue 
bone replacement which have lost the ability to 1s culture is a MEM (minimum essential medium) base with a 
produce the tissue. The tissue could be grown from a sample tri-sugar supplement and fetal bovine s e m n  The Preferred 
and transplanted back to the patient. Also, bone marrow tri-sugar supplement is selected from mixtures of fructose, 
material can be transplanted into a non-autologous recipient. galactose and glucose. 
The organ tissue can be initiated by various normal 
2o mammalian organ cells including skin, small intestine, SUMMARY OF THE INVENTION 
Aggregates of m ~ m a l  m m m d i a n  cells have been Pro- pancreas, liver, colon, and endocrine gland. Predominantly 
d ~ e d  in vitro for each of the three major tissue groups. The normal terminally differentiated cells were able to revert to 
cell aggregates exhibited three di~ensional  tissue growth a state that allowed interaction of a growing cellular mass 
Functional cells with m ~ m a l  morphology have been Pro- 2s non-differentiated cells and without using cell types such as 
for organ, structural and blood Producing tissues. Cell tumor cells that have abnormal cell growth characteristics. 
function was in some cases confirmed immunohistochemi- Artificially produced structural tissue has been produced 
cally by antibodies specific to particular cellular components in microgravity culture conditions from normal 
characterizing cell types. tissue. The three dimensional structural tissue mass devel- 
The aggregates were Produced under ‘‘microgravity CUI- 30 oped with functional chondrocytes and stromal cells with 
ture conditions” which can be microgravity or simulated tissue calcification, The tissue exhibited matrix deposition 
microgravity. Simulated microgravity was created in unit including cells immunochemically characterized as produc- 
gravity by controlling the horizontal rotation of a culture ing Type Iv, Type I x  and Type x collagen, The structural 
Vessel Containing normal InamIndian Cells, Culture matrix tissue is cultured in a vessel at microgravity conditions as 
and completely filled with culture media. In the Preferred 35 described herein with a culture matrix. A preferred culture 
process a horizontally rotating wall culture vessel produced matrix was generally spherical microcarriers, initial 
the simultaneous conditions of (1) collocation of cells and inoculum used in the process to produce the structural tissue 
culture matrix with similar or differing sedimentation prop- mass was nonhuman embryonic cartilage cells disassociated 
erties in a similar spatial region, (2) freedom for three prior to transfer to the culture vessel, 
dimensional spatial orientation of tissues formed by the 4o Three dimensional mammalian blood tissue of normal 
culturing of the cells and (3)  low shear and essentially no origin has been produced artificially. The bone marrow 
relative motion of the culture environment with respect to tissue was prepared from normal bone cells, The 
the walls of the culture vessel. The culture conditions inoculum from the bone include pleuripotential 
included mass transfer under microgravity conditions with stem cells, fully matured white blood cells and red blood 
exchange Of nutrients for 4s cells. The bone marrow cells were transferred into a culture 
gas exchange in the culture system. vessel with fluid culture media and culture matrix. Micro- 
The Process for Producing the normal m m m d i a n  tissue gravity culture conditions as described herein were main- 
is particularly unique in that the resultant product is normal tained while three dimensional tissue growth was achieved, 
tissue of a size of 2 millimeters and larger. The size of the The culture matrix can be disc-shaped, The bone marrow 
tissue cultured is significant because assembly of three 50 can be encased in stromal-like matrices and introduced into 
dimensional masses of this size is not possible without the the vessel, Also, culture matrix of Type I rat tail collagen and 
complex functional interrelationship of the normal mamma- biopolymers can be used, 
lian cells. Relatively large normal mammalian three dimensional 
Functional three dimensional organ tissue masses have tissue masses were cultured using microgravity culture 
been produced artificially from an inoculum of predomi- 5s conditions, The ability of the cells to grow into large 
nantly normal differentiated epithelial cells and predomi- aggregates supports the functional relationship achieved by 
nantlY m ~ m a l  differentiated mesenchymal cells. The epithe- cell to cell contact of normal cells. The process and normal 
lial and mesenchymal cells were preferably disassociated tissue of this invention can be used advantageously as an in 
prior to introduction into the culture vessel. The epithelial vitro produced mammalian product, 
and mesenchymal cells were introduced in a vessel with a 60 
culture matrix preferably of generally spherical microcarri- 
ers. Tissue engineering was achieved by selected introduc- 
tion of the mesenchymal cells and culture matrix for a 
preselected culture period prior to transfer of epithelial cells 
to the culture vessel. 
A three dimensional normal organ tissue mass grew in 
association with the culture matrix having functional epi- 
and functional interrelationship by cell to cell contact. capable of normal organ tissue evolution without using 
waste and 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 is a view at 200x magnification of a three dimen- 
FIG. 2 is a photograph of artificial normal organ tissue at 
FIG. 3 is a photograph of artificial normal organ tissue at 
sional artificial normal organ tissue mass. 
65 200x magnification. 
500x magnification. 
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FIG. 4 is a photograph of artificial normal organ tissue at 
FIG. 5 is a photograph of artificial normal organ tissue at 
FIG. 6 is a photograph of artificial normal structured 
FIG. 7 is a photograph of artificial normal structural tissue 
FIG. 8 is a photograph of artificial normal structural tissue 
FIG. 9 is a photograph of artificial normal structural tissue 
FIG. 10 is a schematic drawing of the blood producing 
1500x magnification. 
50x magnification. 
tissue at 500x magnification. 
at 1500x magnification. 
at 200x magnification. 
at 1500x magnification. 
tissue cells and microcarriers. 
DETAILED DESCRIPTION OF THE 
INVENTION 
Aggregates of cells from the three major tissue groups 
were cultured in vitro. The artificially produced tissue 
masses exhibited normal morphology and cell function. 
Examples of organ tissue, structural tissue and blood tissue 
are described below. 
The artificially produced mammalian organ tissue was 
generated from normal small intestine epithelial and mes- 
enchymal cells. Human small intestine epithelial and mes- 
enchymal cells were obtained from normal organs of 
patients, predominantly organ transplant donors, with no 
evidence of disease. The cells were then propagated in 
culture. The cells were initiated and propagated in M3 media 
supplemented with 2% fetal bovine serum (FBS), designated 
M3:2, for epithelial cells or with 10% FBS, designated 
M3:10, for mesenchymal cells. M3 medium is a complex 
base medium supplemented with many growth factors and 
nutrients including L-Broth (tryptone broth), bovine pitu- 
itary extract, hydrocortizone, essential and non-essential 
amino acids, pentagastrin, epidermal growth factor, 
transferrin, selenium, and insulin. Moyer, “Methods for 
Propagation and Characterization of Human GI and Other 
Cells for Study of HIV,” J .  Tiss. Cult. Meth., Vol. 13, pp. 
107-116 (1991). 
All cell cultures were grown in a Forma humidified CO, 
incubator with 95% air, 5% CO,, and constant atmosphere 
at a temperature of 37” C. Normal mesenchymal cells were 
passaged as required by enzymatic dissociation with a 
solution of 0.1% Trypsin, 0.1% EDTA, for 15 minutes at 37” 
C. After incubation with the appropriate enzymes, the cells 
were centrifuged at 800xG for 10 minutes in Corning 
conical 15-ml centrifuge tubes. The cells were then resus- 
pended in fresh medium and diluted into Corning T-flasks 
with 25 ml of fresh growth medium. Small intestine epithe- 
lial cells were passaged by dilution at a 1:2 ratio into fresh 
M3:2 medium in T-flasks. Cultures of epithelial cells were 
derived from the ileum and jejunum of three male donors 
(22-35 years of age). Mesenchymal cells were obtained 
from the submucosa of five donors (4 males, 17-27 years 
old, and a 2-month-old female). 
Normal mesenchymal cells were removed from T-75 
flasks by enzymatic digestion, washed once with calcium- 
and magnesium-free PBS (CMF-PBS), and assayed for 
viability by Trypan Blue dye exclusion (GIBCO). Cells were 
held on ice in fresh growth medium until inoculation. In the 
preferred process the primary inoculum introduced into the 
culture vessel was 2x10’ mesenchymal cellsiml in a 125-ml 
volume with 5 mgiml Cytodex-3 microcarrier beads 
(Pharmacia, Piscataway, N.J.). Cytodex-3 microcarriers 
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were Type I, collage-coated dextran beads, 175 microns in 
diameter. After the primary inoculum was prepared for 
seeding, it was transferred to a culture vessel filled with 
culture media and cultured at microgravity conditions. 
In a preferred method the microgravity conditions were 
simulated in unit gravity by a horizontal rotating wall vessel 
(RWV). A preferred RWV bioreactor is described in U.S. 
Pat. No. 5,026,650 to Schwarz et al. issued Jun. 25,1991 and 
is incorporated by reference herein. The rotation of the 
culture vessel (bioreactor) was controlled to produce the 
simultaneous conditions of (1) collocation of cells and 
culture matrix with similar or differing sedimentation prop- 
erties in a similar spatial region, (2) freedom for three 
dimensional spatial orientation of tissues formed by the 
culturing of the cells and (3) low shear and essentially no 
relative motion of the culture environment with respect to 
the walls of the culture vessel. The trajectory of the cell 
aggregates was determined. The speed of the rotation of the 
culture vessel was increased if the cell aggregates fell 
excessively inward and downward on the downward side of 
the rotational cycle and excessively outward and insuffi- 
ciently upward on the upgoing side of the rotational cycle to 
prevent wall impact. The rotation of the culture vessel was 
decreased in response to excessive accumulation of tissue 
aggregation near the outer wall of the culture vessel so as not 
to restrict three dimensional growth. As the tissue aggregates 
grow the rotation was adjusted to obtain minimal collision 
frequency and intensity. 
The culture media used in the RWV can be varied. A 1 : l  
mixture of M3:2 medium and standard minimal essential 
medium-alpha (MEM-alpha) (GIBCO) supplemented with 
10% FBS was used. A preferred media designated GTSF-2 
was found to meet the growth requirements of the system 
without the need for unique growth factors and other com- 
plex components found in other media including M3:2. The 
GTSF-2 media is a trisugar-based medium with glucose, 
galactose and fructose supplemented with 6% FBS. A pre- 
ferred formulation for GTSF-2 media is listed in Table 1 
below. The pH was adjusted to 7.4 with 1N NaOH. 
TABLE 1 
Tri-Sugar Based Medium 
GTSF-2 
SourceiOrder 01 
Component Concentration Designation 
MEM-alpha supple- 
mented with 2.25 gmiL 
NaHCO, 
L-15 
NaHCO, 
HEPES 
Folic acid 
0.5% Nicotinic acid 
Bactopeptone 
I-inositoi 
Fructose 
Galactose 
D-Glucose 
300 mM L-Glutamine 
Gentamycin 
Fungizone 
Insulin-transferrin- 
sodium-selenik 
Fetal bovine serum 
400 ml (40%) GIBC01430-1900EB 
600 ml (60%) 
1.35 gmiliter 
3.0 gmiliter 
6.667 ,@liter 
0.667 mliliter 
0.6 gmiliter 
0.024 gmiliter 
0.13 gmiliter 
0.25 gmiliter 
1.0 gmiliter 
10 mliliter 
1 mliliter 
2 mliliter 
5 mliliter 
GIBC01430-1300EB 
Sigmais-5761 
Research Organics/ 
6003H-2 
SigmaiF-8758 
SigmaiN-4126 
Difcoi0118-01 
SigmaiI-5125 
SigmaiF-3510 
SigmaiG-5388 
SigmaiG-5250 
SigmaiG-5763 
GIBC0/600-5750AD 
GIBC01600-5295AE 
SigmaiI-1884 
60 ml (6%) HycloneiA-1111-L 
The primary inoculum of mesenchymal cells was allowed 
to grow for a minimum of 2-3 days before the medium was 
changed. Then 2x10’ epithelial cellsiml were added pre- 
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pared as described above for the mesenchymal cells. The 
organ tissue can be bioengineered to develop desired pat- 
terns of cell layering by preselecting the introduction of the 
epithelial cells into the culture vessel. Also, the cells can be 
introduced essentially simultaneously into the vessel to 
produce normal organ tissue. 
Culture conditions included mass transfer with exchange 
of nutrients for metabolic waste and appropriate gas 
exchange in the culture system. Fresh medium was replen- 
ished by 65% of the total vessel volume each 20 to 24 hours. 
As metabolic requirements increased, fresh medium was 
supplemented with an additional 100 mgidl of glucose. 
Viable cocultures grown in the RWVs were harvested over 
periods up to 45 days and prepared for various assays. 
The artificial organ tissue mass was produced in the RWV 
in both a 1 : l  mixture of M3:2 and MEM alpha supplemented 
with 10% fetal bovine serum (Hyclone Laboratories, Logan, 
Utah) and tri-sugar based media shown in Table 1 on a 
preferred culture matrix of 5 mgiml Cytodex-3 generally 
spherical microcarriers (Pharmacia, LKB). The three dimen- 
sional tissue cultures grown in the M3:2 and MEM media 
attained cell densities of 2.3-3.2~10’ cellsiml and although 
the cultures did not reach plateau phase, suggesting the 
potential for continued growth, the epithelial cell contingent 
exhibited signs of considerable stress while the mesenchy- 
mal cells proliferated well. 
The preferred tri-sugar based media was found to meet the 
growth requirements without the need for multiple growth 
factors and supplements. The cultures in the tri-sugar based 
media produced slightly higher average cell densities, 4.6 to 
6 . 2 ~ 1 0 ~  cellsiml as compared to the M3:2 and MEM media 
which exhibited cell densities of 2 .5-3.2~10~ cellsiml. The 
three dimensional tissue mass grown in the tri-sugar based 
media exhibited an epithelial cell component which 
appeared to proliferate in a more normal and appropriate 
fashion. The cultures were not grown to the plateau phase, 
indicating further capability for continued growth. The arti- 
ficial tissue did not reach maximum cell densities after 
3845 days of culture. 
The tissue masses grew to relatively large sizes as com- 
pared to other in vitro methods. After 300 hours of culture 
the tissueimicrocarrier mass was about 0.2-0.3 cm in size 
with masses increasing to about 0.4-0.6 cm after approxi- 
mately 500 hours of culture and over 0.6 cm after 800 hours 
of culture. 
The epithelial cells and mesenchymal cells used to seed 
the cultures were immunophenotyped and compared to the 
three dimensional tissue cultured in the RWV. Samples were 
harvested at intervals during the culture process for immu- 
nocytochemical analysis. The antibodies used to immu- 
nochemically characterize the cell types are listed in Table 
2 below. 
TABLE 2 
ANTIBODIES USED FOR IMMUNOCYTOCHEMICAL ANALYSIS 
SourceiOrder No. or 
Antibody Specificity Dilution Designation 
Pancytokeratin prediluted DAKO, Inc.lL1824 
Vimentin prediluted DAKO, Inc.IL1843 
Factor VI11 prediluted DAKO, Inc.lL1805 
Villin 1 2 0  Chemicon, Temacria, 
Sucrase 1 2 0  A. Elbein, UTHSCSAIYT 
CAIMAB 1671 
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TABLE 2-continued 
ANTIBODIES USED FOR IMMUNOCYTOCHEMICAL ANALYSIS 
SourceiOrder No. or 5 
Antibody Specificity Dilution Designation 
Angioblasts 1 2 0  Accurate Chem, Westbury, 
Laminin 1 2 0  ICN, Costa Mesa, CAl69- 
Fibronectin 1 2 0  US BIOCH, Cleveland, 
Proteoglycan 1 2 0  Biological Products for 
CAlHE3-5147 
10 630 
OH133752 
Science, Oxford, UWMCA 
326 
1s Collagen Type IV 1 2 0  DAKO, Inc.IM785 
The keratin, vimentin, and Factor VI11 antibodies detect 
epithelial, fibroblastic, and endothelial cells, respectively. 
Villin is a cytoskeletal protein only found in epithelial cells 
20 from small intestine and colon. The angioblast marker is 
present in subsets of precursor endothelial cells, particularly 
dividing cells. Sucrase is an enzyme found in the epithelial 
cell brush border of the small intestine. Basement membrane 
and extracellular matrix components laminin, fibronectin, 
2s Collagen IV, and proteoglycan were also assayed to deter- 
mine their expression in the artificially produced three 
dimensional tissues. 
Cultured organ tissue grown on Cytodex-3 microcarriers 
in the RWV were fixed in OmniFix, an alcohol-based 
30 fixative not containing aldehydes or mercury (Xenetics 
Biochemic, Tustin, Calif.). At all times, extreme care was 
taken not to damage the delicate artificial tissue comprised 
of cellular material and microcarrier beads. When an abun- 
dance of beads was present, the supernatant fluid was 
35 carefully decanted and a sample of beads was enclosed in a 
biopsy bag, then placed in a cassette to prepare a paraffin 
block. When bead clusters were scarce, a Shandon Cytob- 
lock Kit (Shandon Inc., Pittsburgh, Pa.) was used. Cassettes 
were processed in a standard tissue processor. Five-micron 
40 sections were cut from the paraffin-embedded tissues, depar- 
affinized by standard procedures, then assayed by incubation 
with the test antibodies (Table 2) followed by use of the 
universal labeling streptavidin biotin (LSAB) kit (DAKO 
Inc., Carpenteria, Calif., No. K680), which detects mouse 
45 monoclonal and rabbit polyclonal antibodies. The immuno- 
cytophenotyping was confirmed by one positive and two 
negative controls. The positive control was normal tissue 
sections or normal cells positive for the primary antibody 
used. The negative controls were 1) PBS only, to test for 
SO false binding by “link” antibody and streptavidin, and 2) 
normal serum of the same species from which the primary 
antibody was prepared. 
Analysis by immunocytochemistry was used to confirm 
the ability of the seed cells to produce a three dimensional 
ss artificially produced tissue mass with functional epithelial 
cells and functional mesenchymal cells as well as functional 
precursor endothelial cells that were not present in the seed 
culture. As the culture progressed and the tissue mass grew 
it included functional angioblasts. 
Immunophenotyping of the cell types used to seed the 
coculture in the RWV confirmed the majority of epithelial 
and mesenchymal cells seeded were keratin and vimentin 
positive, respectively. In addition, the epithelial cells were at 
various stages of differentiation. Only a small percentage 
65 ( ~ 2 % )  of the cells was positive for Factor VIII, an endot- 
helial cell differentiation marker. Table 3 is a summary of the 
immunochemical staining reaction of the three dimensional 
60 
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tissue of the present invention. The tissue was harvested at 
various intervals up to 41 days as noted in Table 3. 
An increased percentage 210% of cells present in the 
masses consisted of endothelial cells which were Factor VI11 
positive as confirmed by immunochemistry and growing as 
patches on the beads. Furthermore, a small percentage, 
1-2% of cells, showed de novo expression of the HE3 
angioblast antigen which was not present in the seed cultures 
of mesenchymal cells confirming the presence of angioblasts 
in the tissue by immunochemistry. Functional cell brush 
borders were confirmed immunochemically by the presence 
of sucrase. 
FIG. 1 is a photograph of the small intestine artificially 
produced organ tissue at 200x magnification showing the 
three dimensional cell aggregate generally indicated by the 
arrows. FIG. 2 is a photograph of the small intestine organ 
tissue. The triangular markers at 2 and 4 in the photograph 
are for reference on the microcarriers. A mass of epithelial 
cells is shown at 6. Elongated mesenchymal cells are grow- 
ing on the microcarriers as shown at 8 and 10. FIG. 3 is a 
higher magnification (500x) of the epithelial mass shown at 
6 in FIG. 2. FIG. 4 shows the organized columnar epithelial 
cells of the small intestine organ tissue at arrows 12 and 14. 
FIG. 5 shows the three dimensional organ tissue masses 
joined by cord-like structures of fibroblasts (mesenchymal 
cells) covered by epithelial cells. 
TABLE 3 
SUMMARY OF IMMUNOCHEMICAL STAINING ON TISSUE 
GROWTH IN RWV* 
Specificity or Davs Grown in RWV 
Antibodies Cell Stained 13 23 25 37 41 
Keratin 
Vimentin 
Factor VI11 
Villin 
HE3 
Sucrase 
Laminin 
Fibronectin 
Proteoglycan 
C o 11 age n 
Type IV 
Epithelial, Cyto- 
skeletal 
Fibroblasts, some 
endothelial 
Endothelial 
Epithelial, small 
intestine 
Angioblasts 
Small intestine, 
cell brush border 
Basement membrane 
Basement membrane 
Extracellular 
matrix 
Extracellular 
matrix 
+++ +++ 
+++ +++ 
++ +++ 
+ +  
- -  
+++ + 
+ +  
+ +  
++++ ++++ 
++ + 
++ ++ ++ 
++ ++ ++ 
++ ++ ++ 
+ + +  
- ++ ++ 
++ ++ ++ 
- + ++ 
++ ++ - 
++++ ++++ ++++ 
+ ++ ND 
*Slides were observed and scored on a relative scale as - (negative) to ++++ 
(maximum staining; very dark positive for >90% of the cells); + indicates 
weaker staining for -25-50% of the cells; ++ indicates moderate staining for 
greater than SO-75% of the cells. 
Samples from the RWV cultures were taken for scanning 
electron microscopy at the same times as those taken for 
immunocytochemistry. After removal from the reactor 
vessels, samples were washed once with CMF-PBS. The 
samples were suspended in a buffer containing 3% glutaral- 
dehyde and 2% paraformaldehyde in 0.1M cacodylate buffer 
at pH 7.4, then rinsed for 5 minutes with cacodylate buffer 
three times and postfixed with 1% osmium tetroxide 
(Electron Microscopy Sciences, Fort Washington, Pa.) in 
cacodylate buffer for 1 hour. Samples were then rinsed for 
5 minutes with distilled water three times and then treated 
for 10 minutes with Millipore (Millipore Corp., Bedford, 
Ma.) (0.2 p) filtered, saturated solution of thiocarbohy- 
drazide (Electron Microscopy Sciences), then washed for 5 
minutes with distilled water five times and fixed with 1% 
buffered osmium tetroxide for 10 minutes. This last step was 
necessary to prevent the microcarriers from collapsing. 
Samples were then rinsed with distilled water three times 
and dehydrated with increasing concentrations of EtOH 
followed by three changes in absolute methanol. After 
5 transfer to 1, 1, 1, 3, 3, 3-hexamethyldisilazane (HMDS) 
(Electron Microscopy Sciences) samples were allowed to 
soak for 10 minutes, drained, and air dried overnight. Dried 
samples were sprinkled with a thin layer of silver paint on 
a specimen stub, dried, coated by vacuum evaporation with 
platinum-palladium alloy, and then examined in the JEOL 
T330 Scanning electron microscope at an accelerating volt- 
age of 5 to 10 kV. 
Micrographs taken of 6- to 7-day cocultures showed 
partial coverage of the microcarriers by normal small intes- 
tine mesenchymal cells. Additionally, large developing 
masses of small intestine epithelium were evident, growing 
on the microcarrier beadpacks. Samples harvested at 
approximately 12 days of culture contained small microcar- 
rier packs which were totally engulfed in proliferating small 
intestine epithelium. Micrographs of samples at 13 days 
20 displayed large tissue-like masses that were entirely covered 
with small intestine epithelium grown on a base layer of 
mesenchymal cells. Areas of organized columnar epithelium 
were prominent. As the cultures matured into mid- and 
late-stage cultures, extremely complex tissue-like masses 
25 comprised of mesenchymal and epithelial cells were seen 
from approximately 16 days of culture until termination at 
41 days. These tissues were assembled from smaller masses 
which were joined by cord-like structures of fibroblasts and 
covered by epithelial cells several layers deep. In addition, 
30 available microcarriers were drawn to the surface of these 
large masses which were approximately 0.3 to 0.5 cm in 
diameter. Finally, columnar epithelium was observed to be 
growing even in the recessed areas of the microcarrier bead 
packs. 
The artificially produced mammalian structural tissue was 
generated from normal mouse embryonic femurs. The fetal 
cells are a mixture of chondrocytes and stromal cells. The 
cells were placed in a standard media commonly designated 
as CMRL 1066 (Gibco Labs) containing 10% Fetal Bovine 
40 Serum. The cells were disassociated by standard enzymatic 
digestion. The single cells produced by enzymatic digestion 
were washed several times in PBS and transferred into a 
culture vessel with fluid culture media. The preferred culture 
vessel is described in U. S. Pat. No. 5,026,650 and refer- 
45 enced above. The vessel was steam sterilized by autoclaving 
at standard temperature and pressure prior to transfer of the 
cells. 
A preferred culture matrix of generally spherical micro- 
carrier Cytodex-3 beads were transferred into the culture 
50 vessel. The approximate total cell inoculum was 132,000, 
000 at a ratio of 30 cells per Cytodex-3 microcarrier bead. 
The bead concentration of the vessel was 10 mgiml (4000 
beadsimg). The culture media in the vessel was CMRL 1066 
with ascorbic acid 10 mgiml added. 
Microgravity conditions were simulated in culture vessel 
as described and referenced herein. The vessel provided the 
quiescent well-perfused environment for maintenance of 
cell surface receptors and undisturbed cell-to-cell 
co-location. Co-location is important for autocrine-paracrine 
60 factor formation and exchange between cellular types, and 
nurturing of differentiation with consequential matrix depo- 
sition. The cells were cultured for up to 65 days. The tissue 
masses grew to at least 0.4 cm in length after 1000 hours of 
culture. The development of normal cartilage tissue was 
65 evidenced by normal morphology of the chondrocyte and 
stromal cell formation and cartilagineous tissue substruc- 
tures. Also, tissue with calcification was produced. Also, 
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proteoglycan deposition was identified. The normal pattern 
of Type I1 collagen deposition followed by down regulation 
of Type I1 collagen deposition and enhanced formation of 
Type IX and Type X collagen was observed. 
Photographs taken during the culture period of the struc- 
tural cells show the growth and normal development of the 
tissue. FIG. 6 is a micrograph taken at 500x magnification 
at 300 to 600 hours of culture of normal fetal mouse 
chondrocytes. The cells grew around the generally spherical 
microcarriers. FIG. 7 is a higher magnification showing 
preliminary calcification at the arrow 20. FIGS. 8 and 9 were 
taken after 900 to 1100 hours of culture with differentiated 
fibroblastic chondrocytes shown in FIG. 9 at 22. Also, 
stromal cells are show in FIG. 9 at 24. 
The artificially produced blood tissue can be made from 
human bone marrow samples or other sources of mamma- 
lian origin. Human bone marrow samples are obtained by 
standard clinical techniques under aseptic conditions. In 
general, a bone marrow tool is used to puncture the bone and 
obtain a bone marrow sample that is fully inclusive of 
normal constituents. The normal constituents will include, 
but are not limited to: pleuripotential stem cells, fully 
maturated white blood cells and red blood cells, stromal 
components, and cells in intermediate stages of maturation. 
Laboratory animals such as mice can be used as a source 
of bone marrow for selected studies. After sacrificing mice, 
the femur and tibia are removed and placed in l x  Calcium- 
and Magnesium-free PBS with 200 pgiml pen-strep. Muscle 
is removed and endcaps of the bones are cut. With a syringe 
and 26G needle, the bone is flushed with cold complete 
growth medium known to those skilled in the art such as 
CMRL 1066. Cells are then poured through collector screens 
to remove large pieces of tissue and suspended cells are 
placed in 50-cc sterile tubes on cold complete growth 
medium. Cells are washed and centrifuged three times to 
insure no contamination. Cells are not treated with any 
reagent to remove red blood cells. 
The preferred culture vessel is described in U.S. Pat. No. 
5,026,650 previously cited and incorporated by reference 
herein. A fluid culture media is introduced into the sterilized 
vessel. A preferred fluid culture media is a standard tissue 
culture media commonly designated as RPM1-1640 
(available from Gibco and other sources). 
The sterile bone marrow cells are then transferred to fluid 
culture medium and suspended. Suspended cells are 
transferred, at approximate densities of 1x106 cellsiml, to 
the culture vessel. Various cell matrices can be used. The 
collected bone marrow cells can be encased in stromal-like 
matrices. The matrices can be disc-shaped. Other matrices 
are generally known can be used including, but are not 
limited to, collagen matrices of Type I rat tail collagen or 
other biopolymeric matrices. The biopolybers used can be 
biodegradable such as suture materials. Cross-linked poly- 
mers such as collagen, fibronectin and mixtures thereof may 
be used. These matrices may have spherical diameters 
ranging from 1 millimeter to 10 millimeters and include the 
necessary cellular constituents to facilitate primary bone 
marrow culture. Cytodex-3 microcarriers can be introduced 
into the vessel at a density of 5 mgiml. Bone marrow cells 
contained in the matrix or supported in suspension are 
cultured at microgravity conditions and mass transfer as 
described herein and the incorporated references. 
Early in the initiation it is preferable that the cells are 
allowed to grow and metabolize without sampling interrup- 
tion. The first sampling may begin one to seven days after 
inoculation. Consequently, cellular aggregates are not dis- 
turbed and bone marrow growth factors are not diluted by 
14 
media repletion. After the lag phase, media repletion is 
based upon requirements as previously described. Cellular 
phenotyping is carried out by flow cytometry and light 
microscopy. 
FIG. 10 is a schematic drawing of the bone marrow cell 
production. The disc-shaped culture matrices are shown at 
30, 32 and 34. The bone marrow cells are shown as circular 
figures at 36, 38 and 40. The arrows with the GF generally 
indicate the excretion of growth factors from the normal 
i o  bone marrow cells that enhance tissue growth in the culture 
system. 
In the case of preparing bone marrow for recipients, 
volumes are expanded as cellular densities or metabolic 
requirements dictate. The limited parameters may depend 
is upon the rotating vessel’s ability to suspend large 
aggregates, in which case if unable to suspend large 
aggregates, smaller aggregates would be distributed through 
several vessels. If the metabolic requirements were such that 
mass transfer of oxygen and removal of carbon dioxide were 
20 not sufficient to maintain cellular growth and expansion, 
then cells would be aliquoted into additional vessels. 
The examples included are not intended to limit the scope 
of the present invention. Normal mammalian cells have been 
cultured to produce aggregates of cells of three dimensional 
zs tissue masses. Other substitutions, modifications and varia- 
tions are apparent to those skilled in the art without depart- 
ing from the disclosure and scope of the invention. 
s 
What we claim is: 
1. A process for producing functional non-neoplastic 
30 mammalian organ tissue comprising culturing the mamma- 
lian organ tissue in a culture medium, consisting essentially 
O f  
(a) Minimal Essential Medium-alpha (MEM-alpha) 
medium 
3s (b) Leibovitz L-15 medium; 
(c) tri-sugar supplement comprising glucose, galactose, 
(d) serum; 
40 (e) NaHCO,; 
( f )  HEPES; 
(g) folic acid; 
(h) nicotinic acid; 
45 (i) bactopeptone; 
(j) I-inositol; 
(k) L-glutamine; 
(1) gentamycin; 
(m) funguizone; and 
(n) insulin-transferrin-sodium selenite. 
2. The process of claim 1, wherein culturing the mam- 
malian organ tissue in the culture medium comprises the 
following steps: 
(a) inoculating isolated non-neoplastic mammalian cells 
into a culture vessel containing said culture medium; 
(b) culturing the non-neoplastic cells under simulated 
microgravity culture conditions; and 
(c) maintaining the simulated microgravity culture con- 
ditions whereby three dimensional tissue growth is 
achieved, thereby producing functional non-neoplastic 
mammalian organ tissue. 
3. The process of claim 2 wherein the simulated micro- 
gravity culture conditions are created by the culture vessel. 
4. The process of claim 2 wherein the simulated micro- 
gravity culture conditions are created by a horizontal rotat- 
ing wall culture vessel in unit gravity, and wherein the 
and fructose; 
so 
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horizontal rotation of the culture vessel is controlled to 
produce the simultaneous conditions of  
(a) collocation of cells with similar or differing sedimen- 
tation properties in a similar spatial region; 
(b) freedom for three dimensional spatial orientation of ’ 
tissues formed by the culturing of the cells; and 
(c) low shear and essentially no relative motion of the 
culture environment with respect to the walls of the 
culture vessel. conditions of  
5. The process of claim 1, wherein culturing the mam- 
malian organ tissue in the culture medium comprises the 
following steps: 
(c) maintaining the simulated microgravity culture con- 
ditions whereby three dimensional tissue growth is 
achieved thereby producing non-neoplastic mamma- 
lian organ tissue. 
6. The process of claim 5 wherein microgravity culture 
conditions are created by a horizontal rotating wall culture 
vessel in unit gravity, and wherein the horizontal rotation of 
the culture vessel is controlled to produce the simultaneous 
(a) collocation of cells with similar or differing sedimen- 
tation properties in a similar spatial region; 
tissues formed by the culturing of the cells; and 
(c) low shear and essentially no relative motion of the 
culture environment with respect to the walls of the 
culture vessel. 
(a) inoculating isolated non-neoplastic, differentiated epi- (b) freedom for three dimensional spatial orientation of 
thelia1 cells and isolated non-neoplastic, differentiated 1~ 
mesenchymal cells into a horizontal rotating wall cul- 
ture vessel containing said culture medium; 
(b) culturing the epithelial cells and the mesenchymal 
cells under simulated microgravity culture conditions 
and * * * * *  
